These included 1 participant diagnosed with Lynch syndrome, 1 carrier of a variant of unknown clinical significance in the MMR gene appointed to a 2-year surveillance interval, 1 with serrated polyposis syndrome, 14 newly diagnosed individuals with familial CRC syndrome and 2 participants who had withdrawn from surveillance for familial CRC. This evidence concerns the gene MRC1 and Lynch syndrome.